We have entered into an At Market Issuance Sales Agreement, or sales agreement, with MLV & Co. LLC, or MLV, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock from time to time through MLV, acting as agent, having an aggregate offering price of up to $17,900,000.
no room for error
loaded up some here today
seems logical big pharma would want to go up on ROCHE own type of drug that is making billions in profit
sounds like they will announce some news on that once the ink is dry, still in talks now
the conference call mentioned north America and Europe for partnerships in different regions, currently
in talks is how I heard it.....
this was just a conversation point, this is just a minimum price some companies would try to steal shares at,
in relationship to current pps, when the price moves up to a true market value the price target talks would bring $10 to $15 at some point. but sometimes you get a hostile bidder
I went back to listen they said ongoing for north America ,Europe regions once data was announced
to bring phase 3 partner for tivoz.
did they say currently in talks??
25% of 6 BILLION AVEO looking to make new highs this year, buy all you can while its under $2 because
soon it will spike higher when roche is scooping up shares